Interaction with proteoglycans enhances the sterol efflux produced by endogenous expression of macrophage apoE.
Endogenous expression of apolipoprotein (apo)E in macrophages facilitates cholesterol efflux in the presence and absence of extracellular sterol acceptors. A proteoglycan-associated pool of apoE has also been described. The relationship between a proteoglycan-associated pool of apoE and enhanced cholesterol efflux was investigated in these studies. Inhibition of proteoglycan expression reduced cholesterol efflux from apoE-expressing cells ( J774E(+)) in the presence and absence of HDL, but did not do so from nonexpressing cells ( J774E(-)). The effect of proteoglycan depletion on sterol efflux from J774E(+) cells was confirmed by measuring differences in cell sterol mass, secreted sterol mass, and sterol efflux rates. Furthermore, apoE-containing particles secreted from proteoglycan-depleted J774E(+) cells were denser than those secreted from J774E(+) cells with intact proteoglycan expression. Also, in J774E(+) cells with intact proteoglycans, apoE particles isolated from the cell surface proteoglycan layer were denser than secreted particles. The apoE-lipid particles isolated from the cell surface proteoglycan layer had a lower lipid-to-apoE and cholesterol-to-apoE ratio compared with secreted particles. In distinction, proteoglycan depletion of J774E(-) cells did not reduce sterol efflux produced by the exogenous addition of apoE. These observations indicate that one mechanism by which endogenous expression of apoE facilitates effective cholesterol efflux from macrophages is related to its retention at the cell surface in a proteoglycan-associated pool. Further, our data suggest that apoE arrives at the cell surface in a relatively lipid-poor state, and that a proximate source of lipid available to the proteoglycan-bound apoE at the cell surface resides in the plasma membrane.
Lin
C Y
CY
Departments of Medicine and Biochemistry, Rush-Presbyterian-St. Luke's Medical Center, 1653 W. Congress Pkwy, Chicago, IL 60612, USA.
Huang
Z H
ZH
Mazzone
T
T
D000818:Animals; D001057:Apolipoproteins E / Q000096:biosynthesis*; D001665:Binding Sites / Q000502:physiology; D002460:Cell Line / Q000166:cytology; D002784:Cholesterol / Q000819:agonists / Q000378:metabolism; D019763:Heparin Lyase / Q000494:pharmacology; D008075:Lipoproteins, HDL / Q000378:metabolism; D053440:Lipoproteins, HDL3; D008264:Macrophages / Q000166:cytology / Q000378:metabolism*; D011509:Proteoglycans / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*
D001057:Apolipoproteins E; D008075:Lipoproteins, HDL; D053440:Lipoproteins, HDL3; D011509:Proteoglycans; D002784:Cholesterol; D019763:Heparin Lyase